Foghorn Therapeutics Inc (FHTX) — Tangible Net Worth Ratio
Foghorn Therapeutics Inc (FHTX) has a Tangible Net Worth Ratio of 100.0% as of December 2022. This metric is calculated by deducting intangible assets ($0.00) from net assets ($112.00K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Foghorn Therapeutics Inc (FHTX) shareholders funds for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Foghorn Therapeutics Inc Tangible Net Worth Ratio (2020–2022)
This chart shows how Foghorn Therapeutics Inc's Tangible Net Worth Ratio has changed across 3 annual periods from 2020 to 2022. As of December 2022, the ratio stands at 100.0%, reflecting net assets of $112.00K with intangible assets of $0.00 USD. Also explore Foghorn Therapeutics Inc equity growth rate to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Foghorn Therapeutics Inc (2020–2022)
The table below presents the year-by-year Tangible Net Worth Ratio for Foghorn Therapeutics Inc from 2020 to 2022, covering 3 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Foghorn Therapeutics Inc market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 100.0% | $112.00K | $0.00 | $404.88 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $96.87 Million | $0.00 | $519.77 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $146.19 Million | $0.00 | $255.59 Million | — |